Artiva Biotherapeutics, Inc.

Organization

San Diego, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND AN EGFR TARGETED ANTIBODY
- Publication number 20240366664
- Publication date Nov 7, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIG...
- Publication number 20240366663
- Publication date Nov 7, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY
- Publication number 20240197778
- Publication date Jun 20, 2024
- Artiva Biotherapeutics, Inc.
- Yusun KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
- Publication number 20240180962
- Publication date Jun 6, 2024
- Artiva Biotherapeutics, Inc.
- Sungyoo CHO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY
- Publication number 20240115704
- Publication date Apr 11, 2024
- Artiva Biotherapeutics, Inc.
- Peter FLYNN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXPANDED AND STIMULATED NATURAL KILLER CELLS
- Publication number 20240060046
- Publication date Feb 22, 2024
- Artiva Biotherapeutics, Inc.
- Seungryel Han
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY
- Publication number 20240000840
- Publication date Jan 4, 2024
- Artiva Biotherapeutics, Inc.
- Yu Kyeong Hwang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
90559007 - ALLONK
- Serial number 90559007
- Registration number 7056075
- Filing date Mar 4, 2021
- Artiva Biotherapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations

Artiva Biotherapeutics, Inc.

Organization

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

TREATMENT OF CANCER WITH NK CELLS AND AN EGFR TARGETED ANTIBODY

CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTI-CD19 ANTIBODY OR ANTIG...

TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY

TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY

TREATMENT OF CANCER WITH NK CELLS AND A CD38-TARGETED ANTIBODY

EXPANDED AND STIMULATED NATURAL KILLER CELLS

TREATMENT OF CANCER WITH NK CELLS AND A CD20 TARGETED ANTIBODY

Trademarklast 30 trademarks

90559007 - ALLONK